GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
This Quarter Return
+8.03%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$2.02B
AUM Growth
+$2.02B
(+74%)
Cap. Flow
+$659M
Cap. Flow
% of AUM
32.64%
Top 10 Holdings %
Top 10 Hldgs %
42.73%
Holding
194
New
66
Increased
11
Reduced
16
Closed
53
Top Buys
| 1 |
Diamondback Energy
FANG
|
$121M |
| 2 |
Dell
DELL
|
$119M |
| 3 |
GE HealthCare
GEHC
|
$103M |
| 4 |
Trip.com Group
TCOM
|
$83.2M |
| 5 |
LINE
Lineage, Inc. Common Stock
LINE
|
$78.4M |
Top Sells
| 1 |
CCC Intelligent Solutions
CCCS
|
$133M |
| 2 |
Digital Realty Trust
DLR
|
$56.6M |
| 3 |
Kenvue
KVUE
|
$46.3M |
| 4 |
Visa
V
|
$38M |
| 5 |
Enbridge
ENB
|
$26.1M |
Sector Composition
| 1 | Consumer Discretionary | 13.06% |
| 2 | Technology | 12.88% |
| 3 | Healthcare | 12.07% |
| 4 | Real Estate | 11.47% |
| 5 | Energy | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Montrose Environmental
MEG
$1.04B
| $1.84M | 0.09% |
70,000
| – | – |
|
102
ADT
ADT
$7.03B
| $1.81M | 0.09% |
250,000
| – | – |
|
|
GRDN
103
Guardian Pharmacy Services, Inc.
GRDN
$1.74B
| $1.68M | 0.08% |
+100,000
| New | +$1.68M |
|
104
Navigator Holdings
NVGS
$1.08B
| $1.61M | 0.08% |
100,000
| – | – |
|
105
Zeekr
ZK
$7.33B
| $1.56M | 0.08% |
70,000
| – | – |
|
106
Talos Energy
TALO
$1.7B
| $1.55M | 0.08% |
150,000
| – | – |
|
107
Hamilton Insurance Group
HG
$2.37B
| $1.45M | 0.07% |
75,000
-75,000
| -50% | -$1.45M |
|
108
Maplebear
CART
$11.8B
| $1.43M | 0.07% |
35,000
-35,000
| -50% | -$1.43M |
|
|
PAL
109
Proficient Auto Logistics
PAL
$207M
| $1.42M | 0.07% |
100,000
-100,000
| -50% | -$1.42M |
|
110
America's Car Mart
CRMT
$369M
| $1.26M | 0.06% |
+30,000
| New | +$1.26M |
|
111
ArriVent BioPharma
AVBP
$788M
| $1.18M | 0.06% |
50,000
| – | – |
|
112
Wave Life Sciences
WVE
$1.2B
| $1.15M | 0.06% |
+140,000
| New | +$1.15M |
|
113
Loar Holdings
LOAR
$6.81B
| $1.12M | 0.06% |
15,000
+5,000
| +50% | +$373K |
|
114
BridgeBio Pharma
BBIO
$9.84B
| $859K | 0.04% |
33,750
| – | – |
|
115
Savers
SVV
$1.93B
| $789K | 0.04% |
75,000
-75,000
| -50% | -$789K |
|
|
MBX
116
MBX Biosciences, Inc. Common Stock
MBX
$493M
| $779K | 0.04% |
+30,000
| New | +$779K |
|
117
Ascendis Pharma
ASND
$12.1B
| $747K | 0.04% |
+5,000
| New | +$747K |
|
|
SVCO
118
Silvaco Group
SVCO
$154M
| $715K | 0.04% |
50,000
| – | – |
|
|
BIOA
119
BioAge Labs, Inc. Common Stock
BIOA
$168M
| $624K | 0.03% |
+30,000
| New | +$624K |
|
|
GAUZ
120
Gauzy
GAUZ
$96.2M
| $554K | 0.03% |
62,500
-61,510
| -50% | -$546K |
|
121
Torrid Holdings
CURV
$233M
| $393K | 0.02% |
+100,000
| New | +$393K |
|
122
Rithm Capital
RITM
$6.52B
| $369K | 0.02% |
+32,488
| New | +$369K |
|
|
BCAX
123
Bicara Therapeutics Inc. Common Stock
BCAX
$653M
| $255K | 0.01% |
+10,000
| New | +$255K |
|
124
MDxHealth
MDXH
$178M
| $218K | 0.01% |
+105,019
| New | +$218K |
|
125
Pharvaris
PHVS
$1.44B
| $208K | 0.01% |
+11,249
| New | +$208K |
|